A simple and rapid high performance liquid chromatographic method for determination of efavirenz in human plasma was developed. The method involved extraction of sample with ethyl acetate and analysis using a reversed-phase C18 column (150 mm) with UV detection. The assay was linear from 0.0625 to 10.0 �g/ml. The method was specific for efavirenz estimation and the drug was stable in plasma up to one month at −20 ◦C. The average recovery of efavirenz from plasma was 101%. Due to its simplicity, the assay can be used for pharmacokinetic studies and therapeutic drug monitoring of efavirenz
A pharmacokinetic interaction study between efavirenz (EFV), a non-nucleoside reverse transcriptase ...
Efavirenz is a reverse transcriptase non analog nucleoside inhibitor used to treat HIV infections. A...
Abstract: A stability-indicating high performance liquid chromatography (HPLC) method is developed f...
Efavirenz is an anti-viral agent of non-nucleoside reverse transcriptase inhibitor category used as ...
A pharmacokinetic interaction study between efavirenz (EFV), a non-nucleoside reverse transcriptase ...
rapid, specific and accurate isocratic HPLC method was developed and validated for the assay of efav...
rapid, specific and accurate isocratic HPLC method was developed and validated for the assay of efav...
rapid, specific and accurate isocratic HPLC method was developed and validated for the assay of efav...
<p>A rapid, specific and accurate isocratic HPLC method was developed and validated for the assay of...
A stability-indicating high performance liquid chromatography (HPLC) method is developed for the qua...
A selective and a highly sensitive method for the determination of the non-nucleoside reverse transc...
A selective and a highly sensitive method for the determination of the non-nucleoside reverse transc...
Objective: The present study was design with an objective of developing a simple and rapid high perf...
Efavirenz (EFA) is a non-nucleoside reverse transcript-inhibitor (NNRTI) and clinically, it is used ...
A pharmacokinetic interaction study between efavirenz (EFV), a non-nucleoside reverse transcriptase ...
A pharmacokinetic interaction study between efavirenz (EFV), a non-nucleoside reverse transcriptase ...
Efavirenz is a reverse transcriptase non analog nucleoside inhibitor used to treat HIV infections. A...
Abstract: A stability-indicating high performance liquid chromatography (HPLC) method is developed f...
Efavirenz is an anti-viral agent of non-nucleoside reverse transcriptase inhibitor category used as ...
A pharmacokinetic interaction study between efavirenz (EFV), a non-nucleoside reverse transcriptase ...
rapid, specific and accurate isocratic HPLC method was developed and validated for the assay of efav...
rapid, specific and accurate isocratic HPLC method was developed and validated for the assay of efav...
rapid, specific and accurate isocratic HPLC method was developed and validated for the assay of efav...
<p>A rapid, specific and accurate isocratic HPLC method was developed and validated for the assay of...
A stability-indicating high performance liquid chromatography (HPLC) method is developed for the qua...
A selective and a highly sensitive method for the determination of the non-nucleoside reverse transc...
A selective and a highly sensitive method for the determination of the non-nucleoside reverse transc...
Objective: The present study was design with an objective of developing a simple and rapid high perf...
Efavirenz (EFA) is a non-nucleoside reverse transcript-inhibitor (NNRTI) and clinically, it is used ...
A pharmacokinetic interaction study between efavirenz (EFV), a non-nucleoside reverse transcriptase ...
A pharmacokinetic interaction study between efavirenz (EFV), a non-nucleoside reverse transcriptase ...
Efavirenz is a reverse transcriptase non analog nucleoside inhibitor used to treat HIV infections. A...
Abstract: A stability-indicating high performance liquid chromatography (HPLC) method is developed f...